Computational approaches in preclinical studies on drug discovery and development

F Wu, Y Zhou, L Li, X Shen, G Chen, X Wang… - Frontiers in …, 2020 - frontiersin.org
Because undesirable pharmacokinetics and toxicity are significant reasons for the failure of
drug development in the costly late stage, it has been widely recognized that drug ADMET …

Structure-based inhibitor discovery of class I histone deacetylases (HDACs)

Y Luo, H Li - International Journal of Molecular Sciences, 2020 - mdpi.com
Class I histone deacetylases (HDACs) are promising targets for epigenetic therapies for a
range of diseases such as cancers, inflammations, infections and neurological diseases …

[HTML][HTML] In silico analyses of toxicity of the major constituents of essential oils from two Ipomoea L. species

OS da Silva Júnior, CJP Franco, AAB de Moraes… - Toxicon, 2021 - Elsevier
Convolvulaceae Juss. is a family of vines and shrubs composed of species of ecological and
economic importance. Ipomoea asarifolia (Desr.) Roem. & Schult. and I. setifera Poir. are …

Investigation of the effects of porosity and volume fraction on the atomic behavior of cancer cells and microvascular cells of 3DN5 and 5OTF macromolecular structures …

H Wang, A Alizadeh, AM Abed, A Piranfar… - Computers in Biology …, 2023 - Elsevier
Background and objective The molecular dynamics (MD) simulation is a powerful tool for
researching how cancer patients are treated. The efficiency of many factors may be …

Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand-and structure-based virtual screening

H Sirous, G Campiani, V Calderone, S Brogi - Computers in biology and …, 2021 - Elsevier
Histone deacetylases (HDACs) as an important family of epigenetic regulatory enzymes are
implicated in the onset and progression of carcinomas. As a result, HDAC inhibition has …

Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach

Y Sixto-López, M Bello, J Correa-Basurto - Journal of Computer-Aided …, 2020 - Springer
Valproic acid (VPA) is a compound currently used in clinical practice for the treatment of
epilepsy as well as bipolar and mood disorders. VPA targets histone deacetylases (HDACs) …

In the quest for histone deacetylase inhibitors: Current trends in the application of multilayered computational methods

AI Uba, G Zengin - Amino Acids, 2023 - Springer
Histone deacetylase (HDAC) inhibitors have gained attention over the past three decades
because of their potential in the treatment of different diseases including various forms of …

Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking

Y Sixto-López, M Bello… - Journal of Biomolecular …, 2019 - Taylor & Francis
Histone deacetylases (HDACs) are a family of proteins whose main function is the removal
of acetyl groups from lysine residues located on histone and non-histone substrates, which …

The potential effects of clinical antidiabetic agents on SARS‐CoV‐2

H Qu, Y Zheng, Y Wang, H Li, X Liu, X **ong… - Journal of …, 2021 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19), caused by severe acute
respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to …

Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors

A Ibrahim Uba, K Yelekçi - Journal of Biomolecular Structure and …, 2019 - Taylor & Francis
Histone deacetylases (HDACs) are implicated in the pathology of various cancers, and their
pharmacological blockade has proven to be promising in reversing the malignant …